Behavioral Science Aspects of Rapid Testing Acceptance

(ClinicalTrials.gov identifier: NCT01317784)

The Behavioral Science Aspects of Rapid Testing Acceptance (BSARTA) study is funded the National Institute on Drug Abuse (NIDA). The purpose of the study is to examine the accuracy of several new experimental tests for Human Immunodeficiency Virus (HIV), Syphilis, Hepatitis C (HCV) and Hepatitis B (HBV). A rapid test lets you get your test results on the same day that we take the sample. The rapid tests used in this study have not yet been approved by the Food and Drug Administration (FDA). This means that the FDA has not verified the tests’ effectiveness, accuracy or safety. In this study, different combinations of rapid and standard tests will be offered to participants in a four-arm trial to assess which tests are accepted under what conditions, by whom.

Participants will be asked to take part in risk assessment counseling and to complete research questionnaires that will take about an hour and a half to complete. Participants will get free confidential testing for Hepatitis A, Hepatitis B, Hepatitis C (HCV), HIV and syphilis using standard, FDA-approved tests. Some of the standard tests are also rapid. Participants have to come back in one week to get the results of the standard HIV, HCV and syphilis test results and to complete more questionnaires. Participants will get a $20 cash incentive when they get tested, and a $40 cash incentive when they return for their test results. It is very important that participants return for their results.

Participants need to present picture identification that has their date of birth and give blood samples for laboratory testing. Participation in the study is based on eligibility. Not all who inquire are eligible to participate.

For more information please contact us.

Dennis Fisher, Ph.D. (Principal Investigator)
1090 Atlantic Avenue
Long Beach, CA 90813
Phone: (562) 495-2330 ext. 121
Fax: (562) 983-1421